On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans.

Saved in:
Bibliographic Details
Title: On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans.
Authors: Shevach JW; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Aiello LB; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA., Lynch JA; George E. Whalen Veterans Affairs Medical Center, Salt Lake City, UT.; Division of Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT., Petersen J; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Hoffman-Hogg L; Veterans Health Administration National Center for Health Promotion and Disease Prevention, Durham, NC.; Veterans Health Administration Office of Nursing Services, Washington, DC., Hartzfeld D; George E. Whalen Veterans Affairs Medical Center, Salt Lake City, UT., Lundquist M; George E. Whalen Veterans Affairs Medical Center, Salt Lake City, UT., Kelley MJ; Durham VA Medical Center, Durham, NC.; Department of Medicine, Duke University, Durham, NC., Scheuner MT; San Francisco Veterans Affairs Health Care System, San Francisco, CA.; Departments of Medicine and Pediatrics, University of California San Francisco, School of Medicine, San Francisco, CA., Montgomery R; Division of Medical Oncology, University of Washington and Seattle Cancer Care Alliance, Seattle, WA.; Veterans Affairs Puget Sound Health Care System, Seattle, WA., Damjanov N; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Robinson K; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Wong YN; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Jhala D; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Parikh RB; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Maxwell KN; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA.; Department of Medicine-Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Source: JCO oncology practice [JCO Oncol Pract] 2023 Aug; Vol. 19 (8), pp. 637-644. Date of Electronic Publication: 2023 May 23.
Publication Type: Observational Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first